By Editor , 29 October 2026
Aberdeen Carolina & Western Railway Wins $19.9M CRISI Rail Grant

Charlotte – October 29, 2026 -- Aberdeen Carolina & Western Railway (ACWR) has been awarded a $19.9 million federal grant through the U.S. Department of Transportation's Consolidated Rail Infrastructure and Safety Improvements (CRISI) Program to rebuild track laid in the early to mid 1900s.

By Editor , 29 October 2026
Kaiser Permanente Commits $15M to Oakland Pediatric Psychiatric Beds

Oakland – October 29, 2026 -- Kaiser Permanente has awarded a $15 million charitable grant to UCSF Benioff Children's Hospital Oakland to build 20 private inpatient behavioral health rooms, adding capacity to treat approximately 700 children and adolescents a year.

Grant funds a 21,300-square-foot behavioral health wing

The money will pay for construction of the wing as part of the hospital's modernization project. The plan includes an outdoor therapy space and a therapeutic roof garden. The wing is expected to open in 2031.

By Editor , 29 October 2026
AM Best Upgrades The Doctors Company to A+ After ProAssurance Deal

NAPA – October 29, 2026 -- AM Best has raised The Doctors Company's financial strength rating (FSR) to A+ (Superior) from A (Excellent), and its long-term issuer credit rating (ICR) to "aa-" (Superior) from "a+" (Excellent), with a stable outlook.

AM Best affirms A+ ratings across six TDC Group entities

The agency affirmed the A+ FSR, "aa-" ICR and stable outlook for The Doctors Company, an Interinsurance Exchange, and these subsidiaries of The Doctors Company Insurance Group (TDC Group):

By Editor , 29 October 2026
Easol Raises $30M Series A Extension, Totaling $60M Funding

NEW YORK – October 28, 2026 -- Experience commerce platform Easol has raised a $30 million Series A extension, bringing its total funding to $60 million. The round combines $20 million in equity with a $10 million debt facility from Viola Credit.

The equity investors are Y Combinator, Tiger Global, Foundation Capital, FMZ Ventures, Notion Capital and Eight Roads.

By Editor , 29 October 2026
Formation Bio Launches $600M Fund to Acquire 10-15 Drug Programs

New York – October 28, 2026 -- Formation Bio, an AI-native pharmaceutical company, has launched the Formation Bio Drug Development Accelerator Fund with $600 million in capital commitments to expand its portfolio of clinical-stage medicines. The company aims to acquire 10-15 drug programs over the next 3-5 years and advance them through key clinical milestones.

By Editor , 29 October 2026
Plato Raises $16M Series A to Build AI Training Simulations

San Francisco – October 28, 2026 -- Plato, a startup that builds simulated workplaces for training AI models, raised a $16 million Series A round led by Nava Ventures, lifting its total funding to $19 million.

Gradient Ventures, Transpose Platform and Microsoft AI CEO Mustafa Suleyman also participated. Gradient Ventures had led the company's earlier seed round. Nava Ventures founder Freddie Martignetti joins Plato's board.

By Editor , 29 October 2026
Rendezvous Robotics Raises $20M Seed for Self-Assembling Spacecraft

GOLDEN – October 28, 2026 -- Rendezvous Robotics has raised $20 million in an oversubscribed seed round to build spacecraft that assemble themselves in orbit. MaC Venture Capital and Toyota Ventures led the financing, the company's first priced round.

By Editor , 29 October 2026
Frontier Posts Record $1.4B Q3 Revenue, Up 53% as RASM Jumps 30%

DENVER – October 28, 2026 -- Frontier Group Holdings (Nasdaq: ULCC) reported record third-quarter 2026 revenue of approximately $1.4 billion, up 53 percent year-over-year, and returned to an adjusted profit of $40 million despite a 56 percent jump in per-gallon fuel costs.

By Editor , 29 October 2026
AerCap Posts Record Q3 Profit, Lifts 2026 EPS Guidance to $20.70

DUBLIN – October 28, 2026 -- AerCap Holdings N.V. (NYSE: AER) reported record adjusted net income of $1,009 million, or $6.56 per share, for the third quarter of 2026 and raised full-year adjusted earnings per share guidance to approximately $20.70, before any fourth-quarter gains on sale.

GAAP net income was $949 million, or $6.17 per share. GAAP return on equity reached 20%, while adjusted return on equity hit a record 22%. Operating cash flow totaled $1.8 billion.

By Editor , 29 October 2026
Dechra Cuts Scope 1-2 Emissions 27%, Invests 9.6% of Revenue in R&D

BOSTON – October 28, 2026 -- Dechra, a global veterinary specialty care company, reported a 27% cut in Scope 1 and 2 greenhouse gas emissions since its baseline year and R&D spending equal to 9.6% of global revenue in fiscal 2026. The figures come from its 2026 Sustainability Report.